MFCAX
Price
$43.00
Change
+$0.45 (+1.06%)
Updated
Oct 6 closing price
Net Assets
607.5M
VIMSX
Price
$80.68
Change
+$0.06 (+0.07%)
Updated
Oct 6 closing price
Net Assets
201.28B
Interact to see
Advertisement

MFCAX vs VIMSX

Header iconMFCAX vs VIMSX Comparison
Open Charts MFCAX vs VIMSXBanner chart's image
Meridian Contrarian A
Price$43.00
Change+$0.45 (+1.06%)
VolumeN/A
Net Assets607.5M
Vanguard Mid Cap Index Investor
Price$80.68
Change+$0.06 (+0.07%)
VolumeN/A
Net Assets201.28B
MFCAX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
MFCAX vs. VIMSX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFCAX is a StrongBuy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 201B vs. MFCAX (607M). VIMSX pays higher dividends than MFCAX: VIMSX (1.36) vs MFCAX (0.20). MFCAX was incepted earlier than VIMSX: MFCAX (12 years) vs VIMSX (27 years). MFCAX (1.45) is less costly to investors than VIMSX (0.17). MFCAX is a more actively managed with annual turnover of: 58.00 vs. VIMSX (16.00). MFCAX has a lower initial minimum investment than VIMSX: MFCAX (2500) vs VIMSX (3000). MFCAX annual gain was more profitable for investors over the last year : 13.52 vs. VIMSX (12.09). VIMSX return over 5 years is better than : 63.26 vs. MFCAX (25.00).
MFCAXVIMSXMFCAX / VIMSX
Total Expense Ratio1.450.17853%
Annual Report Gross Expense Ratio1.450.17853%
Fund Existence12 years27 years-
Gain YTD15.84511.958133%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets607M201B0%
Annual Yield % from dividends0.201.3615%
Returns for 1 year13.5212.09112%
Returns for 3 years23.2854.5743%
Returns for 5 years25.0063.2640%
Returns for 10 years15.96145.4911%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERA30.940.80
+2.65%
Vera Therapeutics
ATXS7.690.17
+2.26%
Astria Therapeutics
WCC219.503.63
+1.68%
Wesco International
HOVNP20.820.11
+0.53%
Hovnanian Enterprises
HMR1.31-0.02
-1.50%
Heidmar Maritime Holdings Corp